Overview
Tesamorelin Overview
Tesamorelin is a synthetic analog of human growth hormone-releasing hormone (GHRH). It keeps the full 44-amino-acid native sequence and the amidated C-terminus, with one change: a trans-3-hexenoyl group attached to the N-terminal tyrosine.
That small change is what sets it apart. It makes the peptide more resistant to enzymatic cleavage at the N-terminus, giving researchers a more stable tool than native GHRH. In laboratory models, tesamorelin is studied for GHRH receptor binding on pituitary somatotroph cells, cAMP and protein kinase A signaling, the pulsatile pattern of growth hormone release, IGF-1 pathway activity, and lipolytic signaling in adipocyte models.
Each lot is made by solid-phase peptide synthesis, third-party tested, and supplied with a Certificate of Analysis.
| Sequence | trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2 |
|---|---|
| Sequence length | 44 amino acids |
| Also known as | TH9507, (3E)-hex-3-enoylsomatoliberin, N-(trans-3-hexenoyl)-[Tyr1]hGRF(1-44)NH2 |
| Molecular formula | C221H366N72O67S |
| Molecular weight | 5135.86 g/mol |
| CAS number | 218949-48-5 |
| PubChem CID | 16137828 |
| Form | Lyophilized powder |
| Purity | >99% by HPLC, per COA |
| Storage | -20°C, dry, sealed and protected from light |
Certificate of Analysis
| Date | Lot | Certificate |
|---|---|---|
| Tesamorelin - 30mgNov 3, 2026 | 26300703 | View COA |
| Tesamorelin - 10mgNov 3, 2026 | 26050803 | View COA |